ConductScience.org, home

Paper8985191

A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.

Boursnell ME and 11 others. J Infect Dis, 1997. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. Papers, record 8985191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8985191

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease.
PubMed
Journal
J Infect Dis
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
3.64
iCite
Revised in PubMed
2020-04-03
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Boursnell MEM E
2Entwisle CC
3Blakeley DD
4Roberts CC
5Duncan IAI A
6Chisholm SES E
7Martin GMG M
8Jennings RR
9Ni Challanaín DD
10Sobek II
11Inglis SCS C
12McLean CSC S

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Herpes GenitalisMajor topic
Herpesvirus 2, HumanMajor topic
Vaccines, SyntheticMajor topic
Viral VaccinesMajor topic
Animals
Antibodies, Viral
Chlorocebus aethiops
Female
Gene Deletion
Genes, Viral
Guinea Pigs
Immunization Schedule
Recurrence
Transfection
Vaccination
Vaccines, Inactivated
Vero Cells
Viral Envelope Proteins
Virus Replication

Source PubMed

Download CSV of topics

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
40127471Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy.Hum Vaccin Immunother2025https://conductscience.org/library/papers/40127471PubMed
39982077Tackling cutaneous herpes simplex virus disease with topical immunomodulators-a call to action.Clin Microbiol Rev2025https://conductscience.org/library/papers/39982077PubMed
39508503An updated review of HSV-1 infection-associated diseases and treatment, vaccine development, and vector therapy application.Virulence2024https://conductscience.org/library/papers/39508503PubMed
39226323A nonhuman primate model for genital herpes simplex virus 2 infection that results in vaginal vesicular lesions, virus shedding, and seroconversion.PLoS Pathog2024https://conductscience.org/library/papers/39226323PubMed
36851084An Insight into Current Treatment Strategies, Their Limitations, and Ongoing Developments in Vaccine Technologies against Herpes Simplex Infections.Vaccines (Basel)2023https://conductscience.org/library/papers/36851084PubMed
36312660Effective Treatment of Diabetes Mellitus by Resonance Medicine.Cureus2022https://conductscience.org/library/papers/36312660PubMed
35547736Combinatorial Herpes Simplex Vaccine Strategies: From Bedside to Bench and Back.Front Immunol2022https://conductscience.org/library/papers/35547736PubMed
32963118Alphaherpesvirus Vaccines.Curr Issues Mol Biol2021https://conductscience.org/library/papers/32963118PubMed
29899091Immunization by Replication-Competent Controlled Herpesvirus Vectors.J Virol2018https://conductscience.org/library/papers/29899091PubMed
29176979US6 Gene Deletion in Herpes Simplex Virus Type 2 Enhances Dendritic Cell Function and T Cell Activation.Front Immunol2017https://conductscience.org/library/papers/29176979PubMed
28848543A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells.Front Immunol2017https://conductscience.org/library/papers/28848543PubMed
28082979Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.Front Immunol2016https://conductscience.org/library/papers/28082979PubMed
25756612Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.Elife2015https://conductscience.org/library/papers/25756612PubMed
25649429Systemic antibody response to nano-size calcium phospate biocompatible adjuvant adsorbed HEV-71 killed vaccine.Clin Exp Vaccine Res2015https://conductscience.org/library/papers/25649429PubMed
25077372Prospects and perspectives for development of a vaccine against herpes simplex virus infections.Expert Rev Vaccines2014https://conductscience.org/library/papers/25077372PubMed
23843891Towards an effective genital herpes vaccine: past lessons and future prospects.Future Virol2007https://conductscience.org/library/papers/23843891PubMed
23837576A single gD glycoprotein can mediate infection by Herpes simplex virus.J Am Chem Soc2013https://conductscience.org/library/papers/23837576PubMed
23365427Inhibition of the host translation shutoff response by herpes simplex virus 1 triggers nuclear envelope-derived autophagy.J Virol2013https://conductscience.org/library/papers/23365427PubMed
22318147Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread.J Virol2012https://conductscience.org/library/papers/22318147PubMed
22146341Construction of an oncolytic herpes simplex virus that precisely targets hepatocellular carcinoma cells.Mol Ther2012https://conductscience.org/library/papers/22146341PubMed

See all 53 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
GGH8836PubTator's text mininghttps://conductscience.org/library/genes/8836

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8985191

GET https://conductscience.org/api/papers/v1/8985191/cited_by?page=2